Nanoviricides (NNVC) Cash & Equivalents (2010 - 2026)
Nanoviricides (NNVC) recorded Cash & Equivalents of $2.8 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 79.7% from $1.56 million a year earlier but down 12.9% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Cash & Equivalents (2010 - 2026) Analysis & Trends
Starting with fiscal Q1 2011, Nanoviricides' Cash & Equivalents history includes 64 quarters.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -32.9% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Equivalents came in at $1.56 million in FY2025 (-67.5%), $4.8 million in FY2024 (-41.1%), $8.15 million in FY2023 (-42.1%) and $14.07 million in FY2022 (-31.4%).
- Quarterly Cash & Equivalents has ranged from $1.13 million in fiscal Q1 2026 to $19.7 million in fiscal Q1 2022 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for three consecutive quarters, with an average decline of 11.7% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 79.7% in fiscal Q4 2026, against a decline of 71.1% in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $3.21 million (Q3 2026), $5.2 million (Q2 2026) and $1.13 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Nanoviricides | 28.26 Mn | 15.92 Mn | - | 2.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.80 Mn |
| Mar 31, 2026 | 3.21 Mn |
| Dec 31, 2025 | 5.20 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 4.80 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 5.25 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Jun 30, 2023 | 8.15 Mn |
| Mar 31, 2023 | 9.70 Mn |
| Dec 31, 2022 | 11.45 Mn |
| Sep 30, 2022 | 12.92 Mn |
| Jun 30, 2022 | 14.07 Mn |
| Mar 31, 2022 | 15.60 Mn |
| Dec 31, 2021 | 17.34 Mn |
| Sep 30, 2021 | 19.70 Mn |
API Access
Nanoviricides Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();